The large GAAP EPS miss is partly non-cash, but the CFO departure and board turnover add execution risk. Monitor the contingent $5.6M financing milestone (ReWalk sales +150% or stock at $13.80) for potential dilution. Revenue growth and cash improvement are positive, but margin compression and reliance on non-GAAP adjustments warrant caution.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 14 $7.45entry
- T+1 · 3mo ago −0.81%α −0.33% · $7.39
- T+5 · 3mo ago −1.75%α −0.38% · $7.32
- T+20 · 2mo ago −4.56%α −2.57% · $7.11
- T+60 · 8d ago −20.27%α −17.22% · $5.94
Price Chart
How similar events traded
Executive Summary
Lifeward reported Q2 2026 revenue of $6.6M (+16% YoY), slightly above consensus, but GAAP EPS of -$4.12 missed the -$1.28 estimate by 222% due to $6.9M in non-cash warrant remeasurement charges. Cash improved to $9.4M post a $5.6M financing, and the company highlighted a new distribution partnership with Ottobock Care, though gross margin contracted to 41% and the CFO announced departure.
Key Financial Metrics
Key Facts
- Revenue $6.6M (+16% YoY) vs consensus $6.5M (in-line)
- GAAP EPS -$4.12 vs consensus -$1.28 (strong miss)
- Non-GAAP EPS -$1.46 vs consensus -$1.28 (miss)
- Gross margin 41% vs 44% a year ago, pressured by tariffs, FX, and Oramed revenue share
- Cash and equivalents $9.4M at June 30, 2026, up from $2.2M at Dec 31, 2025
- CFO Almog Adar departing effective September 30, 2026
- Board chairman and two directors stepped down August 13, 2026
- Launched pilot program with Ottobock Care for ReWalk exoskeleton distribution
Financial Impact
GAAP net loss of $11.5M in Q2 2026, driven by $6.9M non-cash fair value charges on warrants; revenue grew $0.9M YoY but gross profit margin declined 3ppts
Risk Factors
- Dilution from convertible notes and warrant liabilities
- CFO transition and board changes may disrupt strategy
- Gross margin headwinds from tariffs and FX
- Contingent financing may not be achieved, limiting growth capital
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3345381 |
Track record
25 reports on LFWD
6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +19.89% at T+60 after the Aug 11, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
- Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
- Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
- Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
- Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
- Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
- Aug 14, 202613w ago 8-K Mixed 6/10 No price data
- Aug 14, 202613w ago Press Release Bearish 6/10 Viewing Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
- Aug 11, 202614w ago EFFECT Bearish 7/10 Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers